(KBX) Knorr-Bremse - Overview
Stock: Brake, Valve, Compressor, Sensor, Actuator
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.99% |
| Yield on Cost 5y | 1.82% |
| Yield CAGR 5y | 3.59% |
| Payout Consistency | 94.3% |
| Payout Ratio | 67.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.3% |
| Relative Tail Risk | -6.22% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.10 |
| Alpha | 30.22 |
| Character TTM | |
|---|---|
| Beta | 0.272 |
| Beta Downside | 0.495 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.15% |
| CAGR/Max DD | 0.78 |
Description: KBX Knorr-Bremse January 04, 2026
Knorr-Bremse AG (XETRA:KBX) designs, manufactures and markets brake and safety-critical systems for rail and commercial vehicles, operating through two distinct segments: Rail Vehicle Systems and Commercial Vehicle Systems. The rail segment covers braking, HVAC, coupling, digital traffic-optimization services, and extensive aftermarket support, while the commercial-vehicle side supplies pneumatic brakes, steering, driver-assist, automated-driving components, and power-distribution hardware for trucks, buses, trailers and agricultural machinery.
In FY 2023 the company generated roughly €7.5 billion in revenue with an adjusted EBIT margin around 10 %, reflecting the high-value, engineering-intensive nature of its product mix. Growth is increasingly tied to macro trends such as EU rail-infrastructure upgrades (projected €120 billion in spending through 2030) and the shift toward electric and autonomous commercial vehicles, which drive demand for advanced braking, energy-management and electronic stability solutions.
Key performance levers include the durability of aftermarket service contracts (typically 5-10 years) and the ability to capture market share in emerging electric-truck brake systems, where regulatory safety standards are tightening. Monitoring order-book trends in the European commercial-vehicle market and the rollout pace of rail-electrification projects will be critical for forecasting future earnings.
For a deeper quantitative assessment, see the ValueRay dashboard.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 435.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.85 > 1.0 |
| NWC/Revenue: 28.11% < 20% (prev 26.33%; Δ 1.79% < -1%) |
| CFO/TA 0.12 > 3% & CFO 1.06b > Net Income 435.0m |
| Net Debt (1.73b) to EBITDA (1.20b): 1.45 < 3 |
| Current Ratio: 1.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (161.2m) vs 12m ago 0.0% < -2% |
| Gross Margin: 38.96% > 18% (prev 0.38%; Δ 3858 % > 0.5%) |
| Asset Turnover: 85.67% > 50% (prev 83.95%; Δ 1.72% > 0%) |
| Interest Coverage Ratio: 6.28 > 6 (EBITDA TTM 1.20b / Interest Expense TTM 127.2m) |
Altman Z'' 3.96
| A: 0.25 (Total Current Assets 4.83b - Total Current Liabilities 2.63b) / Total Assets 8.78b |
| B: 0.36 (Retained Earnings 3.15b / Total Assets 8.78b) |
| C: 0.09 (EBIT TTM 799.1m / Avg Total Assets 9.13b) |
| D: 0.53 (Book Value of Equity 3.02b / Total Liabilities 5.67b) |
| Altman-Z'' Score: 3.96 = AA |
Beneish M -3.08
| DSRI: 1.03 (Receivables 1.82b/1.80b, Revenue 7.83b/7.97b) |
| GMI: 0.97 (GM 38.96% / 37.80%) |
| AQI: 1.05 (AQ_t 0.25 / AQ_t-1 0.24) |
| SGI: 0.98 (Revenue 7.83b / 7.97b) |
| TATA: -0.07 (NI 435.0m - CFO 1.06b) / TA 8.78b) |
| Beneish M-Score: -3.08 (Cap -4..+1) = AA |
What is the price of KBX shares?
Over the past week, the price has changed by +6.29%, over one month by +7.64%, over three months by +31.03% and over the past year by +37.50%.
Is KBX a buy, sell or hold?
What are the forecasts/targets for the KBX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 100.6 | -5.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 112.7 | 6% |
KBX Fundamental Data Overview February 03, 2026
P/E Trailing = 36.5985
P/E Forward = 20.0401
P/S = 2.0041
P/B = 5.2394
Revenue TTM = 7.83b EUR
EBIT TTM = 799.1m EUR
EBITDA TTM = 1.20b EUR
Long Term Debt = 2.48b EUR (from longTermDebt, last quarter)
Short Term Debt = 648.0m EUR (from shortTermDebt, last quarter)
Debt = 3.13b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.73b EUR (from netDebt column, last quarter)
Enterprise Value = 17.60b EUR (15.87b + Debt 3.13b - CCE 1.40b)
Interest Coverage Ratio = 6.28 (Ebit TTM 799.1m / Interest Expense TTM 127.2m)
EV/FCF = 21.68x (Enterprise Value 17.60b / FCF TTM 811.9m)
FCF Yield = 4.61% (FCF TTM 811.9m / Enterprise Value 17.60b)
FCF Margin = 10.37% (FCF TTM 811.9m / Revenue TTM 7.83b)
Net Margin = 5.56% (Net Income TTM 435.0m / Revenue TTM 7.83b)
Gross Margin = 38.96% ((Revenue TTM 7.83b - Cost of Revenue TTM 4.78b) / Revenue TTM)
Gross Margin QoQ = 22.85% (prev 54.53%)
Tobins Q-Ratio = 2.00 (Enterprise Value 17.60b / Total Assets 8.78b)
Interest Expense / Debt = 0.93% (Interest Expense 29.0m / Debt 3.13b)
Taxrate = 24.63% (50.0m / 203.0m)
NOPAT = 602.3m (EBIT 799.1m * (1 - 24.63%))
Current Ratio = 1.84 (Total Current Assets 4.83b / Total Current Liabilities 2.63b)
Debt / Equity = 1.03 (Debt 3.13b / totalStockholderEquity, last quarter 3.03b)
Debt / EBITDA = 1.45 (Net Debt 1.73b / EBITDA 1.20b)
Debt / FCF = 2.13 (Net Debt 1.73b / FCF TTM 811.9m)
Total Stockholder Equity = 3.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.76% (Net Income 435.0m / Total Assets 8.78b)
RoE = 14.40% (Net Income TTM 435.0m / Total Stockholder Equity 3.02b)
RoCE = 14.52% (EBIT 799.1m / Capital Employed (Equity 3.02b + L.T.Debt 2.48b))
RoIC = 13.88% (NOPAT 602.3m / Invested Capital 4.34b)
WACC = 5.90% (E(15.87b)/V(19.00b) * Re(6.92%) + D(3.13b)/V(19.00b) * Rd(0.93%) * (1-Tc(0.25)))
Discount Rate = 6.92% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈767.7m ; Y1≈947.0m ; Y5≈1.61b
Fair Price DCF = 280.6 (EV 46.97b - Net Debt 1.73b = Equity 45.24b / Shares 161.2m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -17.59 | EPS CAGR: -0.30% | SUE: -0.31 | # QB: 0
Revenue Correlation: 67.81 | Revenue CAGR: 2.79% | SUE: -0.84 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.03 | Chg30d=+0.010 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=4.58 | Chg30d=+0.006 | Revisions Net=+2 | Growth EPS=+23.5% | Growth Revenue=+5.6%